Bioethics News

FDA Weighs Crackdown That Could Shut Hundreds of Stem Cell Clinics

September 12, 2016

(STAT News) – Scientists on Monday will urge the Food and Drug Administration to crack down on rogue clinics across the country that market stem cell treatments for a dizzying array of ailments from autism to paralysis to erectile dysfunction. But the move comes at an awkward time  — because research on stem cell treatments is just starting to bear fruit. Tantalizing results from a series of small studies suggest injections with certain types of stem cells may be effective treatments for conditions such as stroke and multiple sclerosis.

The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.